A leap in science. A leap toward longevity.
At Health Nucleus, we’ve created a proprietary program that combines the power of data integration and diagnostic insight. It starts with a comprehensive array of advanced testing to collect your unique health data. We then apply state-of-the-art diagnostics to reveal your current health picture that we act upon to help you attain your best health.
Magnetic Resonance Imaging (MRI)
MRI uses powerful magnets, radio waves, and computer technology to generate detailed images of your organs without the use of radiation. Health Nucleus MRI protocols are uniquely beneficial because they employ proprietary software that produces contrast quality imaging without the injection of contrast media. This software aids in the early detection of cancer, cardiac disease, metabolic and neurodegenerative disease.
BODY
Detects many solid organ tumors of the neck, chest, abdomen and pelvis. Increases the chances of early detection to optimize treatment and with certain cancers, can lead to life-long cures.
BRAIN
Generates detailed visualization of the soft tissues and vessels of the brain enabling early intervention for structural, volumetric and vascular abnormalities including tumors, neurodegeneration (Alzheimer’s or Parkinson’s disease) brain vessel narrowing or aneurysms.
HEART*
Provides 3D structural and functional information about the heart, including left ventricle ejection fraction, heart wall motion and valvular evaluation for prevention and treatment of disease. (Cardiac MRI is not designed to evaluate the coronary arteries.)
Learn more about Whole-body MRI
Download our Full Body MRI white paper: Full Body Magnetic Resonance Imaging from Health Nucleus
Whole Genome Sequencing with Annual Re-annotation
Deoxyribonucleic acid (DNA) is the chemical compound that contains much of the “instruction manual” for the 37.3 trillion cells that make up your body. Whole Genome Sequencing (WGS) is the process that defines the order of the four chemical building blocks that make up DNA — adenine, cytosine, thymine, and guanine — and whether this order represents a benign or potentially disease-causing mutation. Sequencing provides enormous amounts of information about the role of inheritance in your susceptibility to disease including single gene mutations that cause cystic fibrosis, hypercholesterolemia and sickle cell anemia or polygenic mutations that are associated with the development of breast, colon, esophageal, and pancreatic cancer, Alzheimer’s and Parkinson’s disease, atrial fibrillation, and more.
Whole Genome Sequencing Evaluates:
- Current risk for disease
- Carrier status for conditions you may pass on to future generations
- Pharmacogenomic profile (your response/non-response to certain medications)
- Physical traits and attributes that can guide lifestyle decisions
- Future risk for disease based upon annual comparison of your genome with the Health Nucleus growing genomic database and the rapidly evolving body of research associated with on-going global discovery
Diagnostics
Coronary Calcium Score* (CT)
Non-Contrast Cardiac CT assesses coronary artery health by detecting the location and extent of calcified plaque in the walls of your coronary arteries. It is a key factor used in the calculation of current and future cardiovascular risk.
Echocardiogram* (ECHO)
Uses ultrasound to visualize and measure the size and shape of your heart, the pumping strength of the left ventricle (ejection fraction) and the real time opening and closing of heart valves. Can indicate the emergence of heart valve disease, left ventricular failure and thickening (hypertrophy) of heart muscle for treatment purposes.
Electrocardiogram* (ECG)
Measures the pattern and wave of electrical energy that travels through the conduction system of the heart indicating whether the heartbeat is normal, slow, fast or irregular. Can also indicate heart muscle thickening or fatigue for clinical management.
Wireless Heart Rhythm
Cardiac monitor placement on the upper left chest records up to two weeks of continuous heart rhythm activity. Information can aid in the detection and treatment of arrhythmias known to be a major cause of stroke.
Balance Tracker
Computes upper body movements (postural sway) that occur when trying to maintain balance during walking. Assesses balance and performance activities to prevent falls and improve physical activity and vitality.
Comprehensive Labs* and Metabolic Analysis
Analysis and reporting of over 40 blood biomarkers testing for anemia and iron status, liver and kidney function, insulin and glucose markers, cholesterol panel with particle size, inflammatory markers, hormones, heavy metals, and certain vitamin nutrient levels.
Insulin Sensitivity Testing
Insulin helps control the amounts of sugar (glucose) in the blood. With insulin resistance, cellular absorption of glucose is impaired and blood sugar levels rise. Treatment is then targeted to avoid progression to Type 2 diabetes.
Dexa* (Dual X‑ray absorptiometry)
Measures bone mineral density and bone strength. Assessment enables the treatment of osteoporosis to prevent fractures.
Metabolomics
Lab measurement of over 900 metabolites — the by-products or residue of bio-chemical reactions that remain in the blood after the metabolism of food and drugs. When balance is disturbed by disease, genetic mutations or environmental factors, one’s metabolic profile changes making metabolites informative biomarkers for understanding disease, toxicity, drug interactions and other factors that impact health.
Multi Targeted Stool DNA Test*
A self-administered, FDA-approved colorectal screening kit for home use, designed to provide an indication of the presence of cancer.
Body Composition
Assessment precisely quantifies visceral fat
(fat stored within the abdominal cavity) and thigh muscle composition. The ratio of fat to muscle may indicate a risk for metabolic syndrome which can lead to heart disease, stroke, type 2 diabetes, breast and colon cancer as well as Alzheimer’s disease.
Sensors
Monitors for day to day health metrics. These could include continuous glucose monitors (CGM), sleep trackers, blood pressure monitors or others. With this data, we can optimize areas of nutrition, sleep, diet, and exercise.
*Only annual if necessary.
All services are available with 100+ enrollment.
The best way to beat the odds is to defy them.
Currently, most diseases aren’t detected until symptoms arise, which can often be too late. The in-depth data we are able to obtain about your body and health enables detection of potential risks years before onset, giving you a chance to proactively avoid the disease entirely. Additionally, early, pre-symptomatic detection of health issues can dramatically decrease the severity of treatment and associated costs.
Risk of preventable, age-related disease in adults age 50 – 74
MALE
FEMALE
25% of US adults who make it to the age of 50 won’t live to age 75. Age 50-74, Adapted from the Institute of Health Metrics and Evaluation, University of Washington
21st century science for a 21st century life span.
Just 100 years ago, the average life span in the US was around 54. Thanks to important achievements in science and health care, today it’s closer to 78. We believe the combination of our technology, analytics, and diagnostic insight has the potential to radically improve and lengthen lives even further — to 100 and beyond.
Knowledge is power. Especially when it comes to your health.
Our data has the power to change and even save lives. In a recent study of over 1,000 of our Health Nucleus patients who were largely asymptomatic, 40% required some form of medical intervention to preempt or treat disease, while 14% required urgent attention. For those without the identification of immediate risks, we can help you make changes to aid in the preemption of disease and creation of your healthiest, most prolific lifestyle.
Clinically significant findings in Health Nucleus clients*
25.6%
Long-term medical findings that require medical attention and monitoring but are not immediately life threatening
Long-term medical findings that require medical attention and monitoring but are not immediately life threatening
14.4%
Significant actionable findings that require immediate or near-term intervention and follow-up
Significant actionable findings that require immediate or near-term intervention and follow-up
60%
Healthy actionable findings that could enhance quality of health and wellbeing
Healthy actionable findings that could enhance quality of health and wellbeing
*Clients screened for the first time.